Acurx pharmaceuticals to discuss third quarter 2024 financial results on november 13, 2024

Staten island, n.y. , oct. 16, 2024 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a late- stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the company will discuss its third quarter 2024 financial results on wednesday, november 13, 2024 at 8:00 am et before the u.s. financial markets open.
ACXP Ratings Summary
ACXP Quant Ranking